Logo.png
PD-1 and PD-L1 Inhibitors Market is Projected to Grow Rapidly During the Study Period (2019–2032) | DelveInsight
20 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- PD-1 and PD-L1 Inhibitors Market is Projected to Grow Rapidly During the Study Period (2019–2032) | DelveInsight   The PD-1 and PD-L1 inhibitor...
Logo.png
Gene Therapies In Ophthalmology Clinical Trial Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
19 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Gene Therapies In Ophthalmology Clinical Trial Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment |...
Logo.png
Burns Market is Projected to Grow During the Study Period (2019–2032), Predicts DelveInsight | Key Players in the Market - Aegle Therapeutics, Skingenix, Inc., Stratatech, MediWound Ltd
15 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Burns Market is Projected to Grow During the Study Period (2019–2032), Predicts DelveInsight | Key Players in the Market - Aegle Therapeutics,...
Logo.png
Gene and Cell Therapies Targeting CNS Disorders Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight
14 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Gene and Cell Therapies Targeting CNS Disorders Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight   The gene and cell...
Logo.png
Diabetic Foot Ulcers Market to Witness Upsurge Growth by 2032, Estimates DelveInsight | Leading Companies - Anterogen Co., Lavior Pharma, Vitruvian Medical Devices, Oneness Biotech Co., Energenesis Biomedical Co.
13 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Diabetic Foot Ulcers Market to Witness Upsurge Growth by 2032, Estimates DelveInsight | Leading Companies - Anterogen Co., Lavior Pharma, Vitruvian...
Logo.png
Primary Hyperoxaluria Market to Exhibit Substantial Growth Rate by 2032, Assesses DelveInsight | Leading Companies - Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, OxThera, Allena Pharmaceuticals, Biocodex
12 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Primary Hyperoxaluria Market to Exhibit Substantial Growth Rate by 2032, Assesses DelveInsight | Leading Companies - Alnylam Pharmaceuticals, Dicerna...
Logo.png
Epilepsy Market to Observe Stunning Growth by 2032, Predicts DelveInsight | Key Players in the Market - Xenon Pharmaceuticals, Aquestive Therapeutics, Takeda, Ovid Therapeutics, Eisai, Biohaven Pharmaceuticals, UCB Pharma
08 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Epilepsy Market to Observe Stunning Growth by 2032, Predicts DelveInsight | Key Players in the Market - Xenon Pharmaceuticals, Aquestive...
Logo.png
Chronic Pain Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Players - Paradigm Biopharmaceuticals, Noven Pharmaceuticals, Pfizer, Biogen, Tonix Pharmaceuticals, Amzell, Bayer, and Others
07 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Chronic Pain Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Players - Paradigm Biopharmaceuticals, Noven...
Logo.png
Crohn's Disease Treatment Drug Market is Expected to Showcase a Significant Growth During Study Period (2019–2032) | DelveInsight
06 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Crohn's Disease Treatment Drug Market is Expected to Showcase a Significant Growth During Study Period (2019–2032) | DelveInsight  The Crohn's...
Logo.png
Hypoparathyroidism Market is Expected to Exhibit Impressive Growth by 2032, Assesses DelveInsight | Leading Companies Developing Therapies - Ascendis Pharma, Amolyt Pharma, Bridgebio, Calcilytix Therapeutics
05 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Hypoparathyroidism Market is Expected to Exhibit Impressive Growth by 2032, Assesses DelveInsight | Leading Companies Developing Therapies - Ascendis...